Purchase Short-Term Access

Review: Androgen deprivation therapy does not increase CV mortality in prostate cancer
Steven E. Canfield, MD; Philipp Dahm, MD, MHSc, FACS

Annals of Internal Medicine 2012;156:JC4-4. doi:10.7326/0003-4819-156-8-201204170-02004

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.